Featured Trends
We’ve sliced and diced our portfolio into distinct “trends” that define our edge.
Climate 100
We are pleased to report that as of April 2021 the SOSV Climate Tech 100 have raised $1.85 billion from investors and have a market cap of $5.65 billion. The average company is four years old. SOSV (our parent fund) has invested $89 million in these companies and was in most cases the first investor, though we continued investing through early rounds.
IndieBio has never been one to shy away from the riskiest and most impactful investments for our planet. In fact, we embrace them.
Female Founder
Boosting female representation in the startup world is an ongoing challenge, but we’re dedicated to gender balance, not only because it’s the right thing to do, but because we would be dismissing impressive companies otherwise. We’ve found that more gender balance leads to better workplace culture and better ideas being exchanged.
Future of Food
It’s not just that we can make meat and fish in the lab, or with mushrooms and chickpeas. It’s not just that AI can predict the best plant ingredients to make the best tasting milk and yogurt. And it’s not just that yeast can be fermented to produce the healthier and better food preservatives. We’re diving deep every day into the foods that will satisfy novelty-seekers and conventionalists alike.
We’re putting big bets on the newest technologies and trends we think are ahead of the curve.
Future of Medicine
Medicine ain’t what it used to be. Today, bloodletting, skull-drilling and giving children cocaine for toothaches are relics of the past. Tomorrow, so too will addictive opioids, chemotherapy, and psychiatric drugs that are non-selectively bathing our bodies in chemicals.
The future of medicine is an exciting one, and we’re excited to share the most exciting technologies that enable the next wave of medicine and healthcare.
Impact
Our mission has always been Human and Planetary Health from the beginning, so it’s hard to say which of our companies are “impact” companies (in some ways, they all are).
Here, we narrowed down the startups that are directly addressing sustainability issues, improving public health, mitigating inequality, and democratizing access to infrastructure and technologies.
Raising Now
These are the companies raising now
Deli and groceraunt meals using fungi proteins.
New Culture biomanufactures casein — the hero proteins — that give cheese characteristic melt, stretchiness and mouthfeel.
Undergoing clinical studies at Stanford right now in prostate cancer, Filtricine
Amino makes learning biotechnology easy and accessible. Their DNA Playground and BioExplorer kits bring bio to any home, school, or makerspace!
Using advanced microbiome science to
solve digestive and skin issues in cats and
dogs, so you can lead them down the path
to a healthier —and happier— life.
Promoter enhancement by circular RNA for gene therapy and biomanufacturing
Dahlia Biosciences is harnessing CRISPR-Cas9 to enable sensitive, robust, and high multiplex single-cell RNA analysis.
Tracking down the drivers of autoimmune diseases through the hidden interactions recorded by T-cell receptors.
Joywell Foods makes protein sweeteners that are sweeter than sugar, without the calories.
Mendel uses machine learning to organize unstructured electronic medical record and clinical literature into compliant data.